Effects of chronic triclosan exposure upon the antimicrobial susceptibility of 40 ex-situ environmental and human isolates

Journal of Applied Microbiology

Volumn 100, Issue 5, 2006, Pages 1132-1140

  Ledder, R G ^a   Gilbert, P ^a   Willis, C ^b   McBain, A J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Antibiotics; Cross resistance; Ex situ; Low passage isolates; Resistance; Triclosan

Indexed keywords

ESCHERICHIA COLI;

ACYL CARRIER PROTEINS; ANTIMICROBIAL SUSCEPTIBILITY; BACTERIAL GENUS; CHLORHEXIDINE; CROSS RESISTANCE; E. COLI; EX SITU; LOW PASSAGE ISOLATE; RESISTANCE; TRICLOSAN;

ANTIBIOTICS;

ANTIBIOTIC AGENT; CHLORAMPHENICOL; CHLORHEXIDINE; CIPROFLOXACIN; METRONIDAZOLE; NALIDIXIC ACID; TETRACYCLINE; TRICLOSAN;

ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; COLIFORM BACTERIUM; DATA INTERPRETATION; DOMESTIC WASTE; PROTEIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARANICOLA PROTEOLYTICUS; ARTICLE; AXILLA; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA ANALYSIS; DRUG EXPOSURE; ENTEROBACTERIACEAE; ENVIRONMENT; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; KLEBSIELLA OXYTOCA; LONG TERM EXPOSURE; MOUTH FLORA; NONHUMAN; NUCLEOTIDE SEQUENCE; STENOTROPHOMONAS MALTOPHILIA;

ARANICOLA PROTEOLYTICUS; BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; NEGIBACTERIA; STENOTROPHOMONAS MALTOPHILIA;

EID: 33645845404     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2006.02811.x     Document Type: Article

References (33)

1. Aiello A.E. Marshall B. Levy S.B. Della-Latta P. Larson E. 2004 Relationship between triclosan and susceptibilities of bacteria isolated from hands in the community. Antimicrob Agents Chemother 48 2973 2979.
2. Ayliffe G.A. Babb J.R. Davies J.G. Lilly H.A. 1988 Hand disinfection: a comparison of various agents in laboratory and ward studies. J Hosp Infect 11 226 243.
3. Bamber A.I. Neal T.J. 1999 An assessment of triclosan susceptibility in methicillin-resistant and methicillin-sensitive Staphylococcus aureus. J Hospital Infect 41 107 109.
4. Bhargava H. N. Leonard P.A. 1996 Triclosan: applications and safety. Am J Infect Control 24 209 218.
5. Braoudaki M. Hilton A.C. 2004a Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and Cross resistance to antimicrobial agents. J Clin Microbiol 42 73 78.
6. Braoudaki M. Hilton A.C. 2004b Low level of cross resistance between triclosan and antibiotics in Escherichia coli K12 and E. coli O55 compared to E. coli O151. FEMS Microbiol Lett 235 305 309.
7. Chuanchuen R. Beinlich K. Hoang T.T. Becher A. Karkhoff-Schweizer R.R. Schweizer H.P. 2001 Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother 45 428 432.
8. Chuanchuen R. Narasaki C.T. Schweizer H.P. 2002 The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan. J Bacteriol 184 5036 5044.
9. Cole E.C. Addison R.M. Rubino J.R. Leese K.E. Dulaney P.D. Newell M.S. Wilkins J. Gaber D.J. et al. 2003 Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers. J Appl Microbiol 95 664 676.
10. Eley B.M. 1999 Antibacterial agents in the control of supragingival plaque - a review. British Dental Journal 186 286 296.
11. Furia T.E. Schenkel A.G. 1968 A new, broad spectrum bacteriostat. Soap Chem Spec 44 47 50 and 116 122.
12. George A.M. Levy S.B. 1983 Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid determined efflux of tetracycline. J Bacteriol 155 531 540.
13. Heath R.J. Rubin J.R. Holland D.R. Zhang E. Snow M.E. Rock C.O. 1999 Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J Biol Chemistry 274 1110 1114.
14. Irish D. Eltringham I. Teall A. Pickett H. Farelly H. Reith S. Woodford N. Cookson B. 1998 Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin. J Hosp Infect 39 19 26.
15. Jones R.D. Jampani H.B. Newman J.L. Lee A.S. 2000 Triclosan: a review of effectiveness and safety in health care settings. American J Infect Control 28 184 196.
16. Kwochka K.W. Kowalski J.J. 1991 Prophylactic efficacy of four antibacterial shampoos against Staphylococcus intermedius in dogs. Am J Vet Res 52 115 118.
17. Levy S.B. 2001. Antibacterial household products: cause for concern. Emerging Infectious Diseases 7 512 515.
18. McBain A.J. Gilbert P. 2001 Biocide tolerance and the harbingers of doom. Int Biodeterior Biodegrad 47 55 61.
19. McBain A. J. Macfarlane G.T. 1998 Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites. J Med Microbiol 47 407 16.
20. McBain A.J. Bartolo R.G. Catrenich C.E. Charbonneau D. Ledder R.G. Gilbert P. 2003a Effects of triclosan-containing dentifrice upon the dynamics and antimicrobial susceptibility of in-vitro plaque ecosystems. Antimicrob Agents Chemotherapy 11 3531 3538.
21. McBain A.J. Bartolo R.G. Catrenich C.E. Charbonneau D. Ledder R.G. Gilbert P. 2003b Exposure of sink drain microcosms to triclosan: population dynamics and antimicrobial susceptibility. Appl Environ Microbiol 69 5433 5442.
22. McBain A.J. Ledder R.G. Sreenivasan, P. Gilbert P. 2004 Selection for high-level resistance by chronic triclosan exposure is not universal. J Antimicrob Chemother 53 772 777.
23. McMurry L.M. Oethinger M. Levy S.B. 1998a q12 Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 166 305 309.
24. McMurry L.M. Oethinger M. Levy S.B. 1998b q13 Triclosan targets lipid synthesis. Nature 394 531 532.
25. Meade M.J. Waddell R.L. Callahan T.M. 2001 Soil bacteria Pseudomonas putida and Alcaligenes xylosoxidans subsp. denitrificans inactivate triclosan in liquid and solid substrates. FEMS Microbiol Lett 204 45 48.
26. Moken M.C. McMurry L.M. Levy S.B. 1997 Selection of multiple-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci. Antimicrobial Agents Chemother 41 770 772.
27. Randall L.P. Cooles S.W. Piddock L.J. Woodward M.J. 2004 Effect of triclosan or a phenolic farm disinfectant on the selection of antibiotic-resistant Salmonella enterica. J Antimicrob Chemother 54 621 627.
28. Regos J. Zak O. Solf R. Vischer W.A. Weirich E.G. 1979 Antimicrobial spectrum of triclosan, a broad-spectrum antimicrobial agent for topical application. II. Comparison with some other antimicrobial agents. Dermatologica 158 72 79.
29. Russell A.D. 2004 Whither triclosan J Antimicrob Chemother 53 693 695.
30. Schweizer H.P. 2001 Triclosan: a widely used biocide and its link to antibiotics. FEMS Microbiol Lett 202 1 7
31. Villalain J. Mateo C.R. Aranda F.J. Shapiro S. Micol V. 2001 Membranotropic effects of the antibacterial agent Triclosan. Arch Biochem Biophys 390 128 136.
32. Zafar A.B. Butler R.C. Reese D.J. Gaydos L.A. Mennonna P.A. 1995 Use of 0·3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 23 200 208.
33. Zgurskaya H.I. Nikaido H. 2000 Multidrug resistance mechanisms: drug efflux across two membranes. Molecular Microbiol 37 19 225.